Curatis Holding AG's book value per share for the quarter that ended in Dec. 2025 was CHF8.94.
During the past 12 months, Curatis Holding AG's average Book Value Per Share Growth Rate was -5.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -30.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Curatis Holding AG was -30.60% per year. The lowest was -30.60% per year. And the median was -30.60% per year.
Curatis Holding AG's current price is CHF23.90. Its book value per share for the quarter that ended in Dec. 2025 was CHF8.94. Hence, today's PB Ratio of Curatis Holding AG is 2.67.
During the past 5 years, the highest P/B Ratio of Curatis Holding AG was 2.80. The lowest was 1.04. And the median was 1.34.
Warning Sign:
Curatis Holding AG stock PB Ratio (=2.67) is close to 2-year high of 2.8.
Curatis Holding AG (XSWX:CURN) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Curatis Holding AG Book Value per Share Related Terms
Curatis Holding AG Book Value per Share Historical Data
* Premium members only.
The historical data trend for Curatis Holding AG's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CURN vs ZTS, UTHR, VTRS: Book Value per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curatis Holding AG PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Curatis Holding AG's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curatis Holding AG (XSWX:CURN) has a Book Value per Share of CHF8.94 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Curatis Holding AG and its competitors.
Is Curatis Holding AG's Book Value per Share too high?
Curatis Holding AG's current Book Value per Share is CHF8.94. Overall, Curatis Holding AG has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Book Value per Share compare to ZTS and UTHR?
Curatis Holding AG's Book Value per Share of CHF8.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Curatis Holding AG and its competitors. Curatis Holding AG's current Book Value per Share is CHF8.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Book Value per Share of CHF8.94. The current Book Value per Share is CHF8.94. Curatis Holding AG's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Book Value per Share is CHF8.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
31GF Score
Get the complete analysis for XSWX:CURN
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CURN has been successfully added to your 
